Selatox Bio Pharma will participate in the 2026 International Aesthetics Congress, presenting manufacturing discipline, quality systems, and product science to a global audience of clinicians, distributors, and industry specialists. The company's pavilion will feature interactive exhibits on cold-chain integrity, batch traceability, and the analytical methods used to support release decisions.
Delegates are invited to schedule meetings with medical affairs and commercial teams to discuss partnership models, training pathways, and pharmacovigilance reporting expectations for new accounts. Session topics led by Selatox experts will include GMP scale-up lessons from Indonesia, practical considerations for injection safety, and evidence-based approaches to patient counseling in aesthetic practice.
A dedicated theater program will showcase case discussions moderated by regional key opinion leaders, emphasizing anatomical planning, conservative dosing strategies, and follow-up documentation that strengthens long-term patient relationships. Printed and digital resources will be available in multiple languages, with QR-linked portals for verified product information.
Selatox will also host a closed-door workshop for distribution partners focused on inventory planning, returns governance, and compliant promotional practices. Attendance is limited to credentialed organizations with active agreements or advanced onboarding status.
Media representatives may request interviews through the congress press desk or by contacting the Selatox corporate communications team in advance. Photography within the pavilion is permitted during published hours, subject to patient-privacy policies that prohibit capture of identifiable treatment demonstrations without consent.
